Literature DB >> 21686961

Familial 4.3 Mb duplication of 21q22 sheds new light on the Down syndrome critical region.

Anne Ronan1, Kerry Fagan, Louise Christie, Jeffrey Conroy, Norma J Nowak, Gillian Turner.   

Abstract

A 4.3 Mb duplication of chromosome 21 bands q22.13-q22.2 was diagnosed by interphase fluorescent in situ hybridisation (FISH) in a 31 week gestational age baby with cystic hygroma and hydrops; the duplication was later found in the mother and in her 8-year-old daughter. All had the facial gestalt of Down syndrome (DS). This is the smallest accurately defined duplication of chromosome 21 reported with a DS phenotype. The duplication encompasses the gene DYRK1 but not DSCR1 or DSCAM. Previous karyotype analysis and telomere screening of the mother, and karyotype analysis and metaphase FISH of a chorionic villus sample, had all failed to reveal the duplication. The findings in this family add to the identification and delineation of a "critical region" for the DS phenotype on chromosome 21.

Entities:  

Year:  2009        PMID: 21686961      PMCID: PMC3027932          DOI: 10.1136/bcr.05.2009.1914

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  30 in total

Review 1.  Increased nuchal translucency in fetuses with a normal karyotype.

Authors:  Jon A Hyett
Journal:  Prenat Diagn       Date:  2002-10       Impact factor: 3.050

2.  Partial trisomies of chromosome 21 in man. Two new observations due to translocations 19;21 and 4;21.

Authors:  R A Pfeiffer; E K Kessel; K H Soer
Journal:  Clin Genet       Date:  1977-03       Impact factor: 4.438

3.  Two cases of partial trisomy 21 (pter-q22.1) without the major features of Down syndrome.

Authors:  Yoko Kondo; Seiji Mizuno; Kei Ohara; Takeshi Nakamura; Kenichiro Yamada; Shunji Yamamori; Chiemi Hayakawa; Takashi Ishii; Yasukazu Yamada; Nobuaki Wakamatsu
Journal:  Am J Med Genet A       Date:  2006-02-01       Impact factor: 2.802

4.  Clinical, cytogenetic, and molecular evaluation of a patient with partial trisomy 21 (21q11-q22) lacking the classical Down syndrome phenotype.

Authors:  C A Williams; J L Frias; M K McCormick; S E Antonarakis; E S Cantu
Journal:  Am J Med Genet Suppl       Date:  1990

5.  Down syndrome with partial duplication and del (21) syndrome: study protocol and call for collaboration. Study I: Clinical assessment.

Authors:  A J Barnicoat; J L Bonneau; E Boyd; Z Docherty; S J Fennell; J L Huret; M King; E L Maltby; S McManus; D T Pilz; E Shafei-Benaissa; M Super; J Tolmie
Journal:  Clin Genet       Date:  1996-01       Impact factor: 4.438

6.  Two Down syndrome patients with rec(21),dupq,inv(21)(p11;q2109) from a familial pericentric inversion.

Authors:  C Léonard; M Gautier; P M Sinet; J Selva; J L Huret
Journal:  Ann Genet       Date:  1986

7.  DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways.

Authors:  J J Fuentes; L Genescà; T J Kingsbury; K W Cunningham; M Pérez-Riba; X Estivill; S de la Luna
Journal:  Hum Mol Genet       Date:  2000-07-01       Impact factor: 6.150

Review 8.  The natural history of euploid pregnancies with first-trimester cystic hygromas.

Authors:  P M Trauffer; C E Anderson; A Johnson; S Heeger; P Morgan; R J Wapner
Journal:  Am J Obstet Gynecol       Date:  1994-05       Impact factor: 8.661

9.  Atypical Down syndrome and partial trisomy 21.

Authors:  E C Jenkins; C J Duncan; C E Wright; F M Giordano; L Wilbur; K Wisniewski; S L Sklower; J H French; C Jones; W T Brown
Journal:  Clin Genet       Date:  1983-08       Impact factor: 4.438

10.  Molecular genetic approach to the characterization of the "Down syndrome region" of chromosome 21.

Authors:  M K McCormick; A Schinzel; M B Petersen; G Stetten; D J Driscoll; E S Cantu; L Tranebjaerg; M Mikkelsen; P C Watkins; S E Antonarakis
Journal:  Genomics       Date:  1989-08       Impact factor: 5.736

View more
  2 in total

1.  Dyrk1 inhibition improves Alzheimer's disease-like pathology.

Authors:  Caterina Branca; Darren M Shaw; Ramona Belfiore; Vijay Gokhale; Arthur Y Shaw; Christopher Foley; Breland Smith; Christopher Hulme; Travis Dunckley; Bessie Meechoovet; Antonella Caccamo; Salvatore Oddo
Journal:  Aging Cell       Date:  2017-08-04       Impact factor: 9.304

Review 2.  Modeling human neurodevelopmental diseases with brain organoids.

Authors:  Xiaoxiang Lu; Jiajie Yang; Yangfei Xiang
Journal:  Cell Regen       Date:  2022-01-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.